InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the complete record of transactions filed by Takanashi Ken. Insider active across 3 companies, notably Satsuma Pharmaceuticals, Inc.. Cumulatively, 6 reports have been logged. Split: 1 buy · 2 sells. Total volume traded: €18.8m. Activity tracked since 6 June 2023. The latest transaction was disclosed on 11 August 2026 (Cession). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 条申报中的 6 条
TAKANASHI KEN is a Director of Wave Life Sciences Ltd., WAVE LIFE SCIENCES, INC., and Satsuma Pharmaceuticals, Inc. Across the 6 filings on record, the sampled recent filings cover the period from 2023-06-08 to 2026-08-13, with EUR 18759272 of buying and EUR 56920 of selling, and the modal transaction nature is Sale.